US Stock MarketDetailed Quotes

ALLO Allogene Therapeutics

Watchlist
  • 1.870
  • +0.030+1.63%
Close Dec 20 16:00 ET
  • 1.900
  • +0.030+1.60%
Post 17:42 ET
392.09MMarket Cap-1.21P/E (TTM)

Allogene Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Allogene Therapeutics Q3 2024 Earnings Date

Currency：USDNov 7, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
10.00K
0
-10.00K
Miss Est.
-76.74%
-100.00%
-100.00%
EPS
-0.33
-0.32
+<0.01
Beat Est.
+11.49%
+13.51%
+2.26%
Analyst Rating
Strong Buy

Nov 30, 2024

Allogene Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 12 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 4.170K--
--2024/Q4-- / 12.110K--
Nov 7, 20242024/Q30.000 / 10.000K--
Aug 7, 20242024/Q20.000 / 1.777M--
May 13, 20242024/Q122.000K / 10.430K--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 4.170K--
--2024/Q4-- / 12.110K--
Nov 7, 20242024/Q30.000 / 10.000K--
Aug 7, 20242024/Q20.000 / 1.777M--
May 13, 20242024/Q122.000K / 10.430K--

Unlock Free Earnings Estimates

Allogene Therapeutics Earnings Reports

  • Allogene Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 8 05:20

  • Allogene Therapeutics | 8-K: Allogene Therapeutics Reports Third Quarter 2024 Financial Results and Business Update

    Nov 8 05:10

  • Allogene Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 8 04:14

  • Allogene Therapeutics | 8-K: Allogene Therapeutics Reports Second Quarter 2024 Financial Results and Business Update

    Aug 8 04:07

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 30, 2024

    Strong Buy

    • Buy

      80.00%

    • Hold

      20.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data